check_circleStudy Completed

Cystic fibrosis

Bayer Identifier:

Trial_0512

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
Study to Compare the Safety and Efficacy of Ciprofloxacin with Intravenous Ceftazidime and Tobramycin in the Treatment of Pediatric Cystic Fibrosis Patients with Acute Pulmonary Exacerbation

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

N/A

Age

5 - 18 Years
  • -

  • -

Trial summary

Enrollment Goal
84
Trial Dates
February 1992 - August 1994
Phase
Phase 3
Could I Receive a placebo
N/A
Products
Cipro IV (Ciprofloxacin, BAYQ3939)
Accepts Healthy Volunteer
N/A

Trial design

Prospective, Randomized, Third-Party Blind Study to Compare the Safety and Efficacy of Ciprofloxacin (Sequential IV/PO) with Intravenous Ceftazidime and Tobramycin in the Treatment of Pediatric Cystic Fibrosis Patients with Acute Pulmonary Exacerbation
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.